Brought to you by 
Evalve gets $60mm through its Series D round
11 Dec 2007
Executive Summary
Evalve (devices used in percutaneous repair of cardiac valves) has raised $60mm through the closing of its Series D venture round. BBT Fund led the financing and was joined by returning backers Delphi Ventures, New Enterprise Associates, Split Rock Partners, and Abbott Laboratories. The funds will go towards European marketing of MitraClip, which is used to treat regurgitation by repairing the patient's mitral valve, and for a pivotal study of the device in the US.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Evalve gets $60mm through its Series D round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice